Retinal cAMP levels during the progression of retinal degeneration in rhodopsin P23H and S334ter transgenic rats

Investigative Ophthalmology and Visual Science

Volumn 43, Issue 5, 2002, Pages 1655-1661

  Traverso, Valerie ^a   Bush, Ronald A ^a   Sieving, Paul A ^a   Deretic, Dusanka ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; RHODOPSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DARK ADAPTATION; GENE MUTATION; IMMUNOASSAY; NONHUMAN; PHOTORECEPTOR; PRIORITY JOURNAL; RAT; RETINA DEGENERATION; RETINA ROD; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CELL COUNT; CYCLIC AMP; DARK ADAPTATION; DISEASE PROGRESSION; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MUTATION; PHOTORECEPTORS, VERTEBRATE; RATS; RATS, SPRAGUE-DAWLEY; RETINAL DEGENERATION; RHODOPSIN;

EID: 0036240690     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. A brief review of retinitis pigmentosa and the identified retinitis pigmentosa genes
2. Prevalence of mutations causing retinitis pigmentosa and other inherited retinopathies
3. Apoptosis: Final common pathway of photoreceptor death in rd, rds, and rhodopsin mutant mice
4. Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa
5. Mechanisms of photoreceptor death and survival in mammalian retina
6. Mechanisms of cell death in the inherited retinal degenerations
7. Apoptosis in the retina: The silent death of vision
8. Altered cAMP levels in retinas from transgenic mice expressing a rhodopsin mutant
9. Alterations in cyclic AMP metabolism associated with photoreceptor cell degeneration in the C3H mouse
10. Cyclic nucleotide content and phosphodiesterase activity in the rds mouse (020/A) retina
11. Alpha 2-adrenergic agonists induce basic fibroblast growth factor expression in photoreceptors in vivo and ameliorate light damage
12. The role of melatonin and dopamine in retinal physiology
13. Melatonin increases photoreceptor susceptibility to light-induced damage
14. The melatonin antagonist luzindole protects retinal photoreceptors from light damage in the rat
15. Circadian rhythmicity in vertebrate retinas: Regulation by photoreceptor oscillator
16. Circadian rhythms of melatonin biosynthesis in retinal photoreceptor cells: Signal transduction, interactions with dopamine, and speculations on a role in cell survival
17. Light stimulates tyrosine hydroxylase activity and dopamine synthesis in retinal amacrine neurons
18. Cyclic AMP-dependent induction of serotonin N-acetyltransferase activity in photoreceptot-enriched chick retinal cell cultures: Characterization and inhibition by dopamine
19. Photoreceptors of mouse retinas possess D4 receptors coupled to adenylate cyclase
20. Dopamine inhibits melatonin synthesis in photoreceptor cells through a D2-like receptor subtype in the rat retina: Biochemical and histochemical evidence
21. Melatonin is a potent modulator of dopamine release in the retina
22. Regulation of indoleamine N-acetyltransferase activity in the retina: Effects of light and dark, protein synthesis inhibitors and cyclic nucleotide analogs
23. Darkness stimulates rapid synthesis and release of melatonin in rat retina
24. Melatonin increases serotonin N-acetyltransferase activity and decreases dopamine synthesis in light-exposed chick retina: In vivo evidence supporting melatonin-dopamine interaction in retina
25. Photoreceptor outer segments: Accelerated membrane renewal in rods after exposure to light
26. Methoxyindoles and photoreceptor metabolism: Activation of rod shedding
27. Photomechanical movements of cultured embryonic photoreceptors: Regulation by exogenous neuromodulators and by a regulable source of endogenous dopamine
28. Novel rhodopsin mutations Gly114Val and Gln184Pro in dominant retinitis pigmentosa
29. A point mutation of the rhodopsin gene in one form of retinitis pigmentosa
30. Rhodopsin mutations in autosomal dominant retinitis pigmentosa
31. Transgenic mice with a rhodopsin mutation (Pro23His): A mouse model of autosomal dominant retinitis pigmentosa
32. Simulation of human autosomal dominant retinitis pigmentosa in transgenic mice expressing a mutated murine opsin gene
33. Characterization of rhodopsin mis-sorting and constitutive activation in a transgenic rat model of retinitis pigmentosa
34. Transgenic rat models of inherited retinal degeneration caused by mutant opsin genes
35. Rhodopsin accumulation at abnormal sites in retinas of mice with a human P23H rhodopsin transgene
36. Defective phototransductive disk membrane morphogenesis in transgenic mice expressing opsin with a mutated N-terminal domain
37. Ocular findings in patients with autosomal dominant retinitis pigmentosa and rhodopsin, proline-347-leucine
38. Rhodopsin mutation proline-347-to-alanine in a family with autosomal dominant retinitis pigmentosa indicates an important role for proline at position 347
39. Clinical expression correlates with location of rhodopsin mutation in dominant retinitis pigmentosa
40. Cytoplasmic domain of rhodopsin is essential for post-Golgi vesicle formation in a retinal cell-free system
41. Regulation of sorting and post-Golgi trafficking of rhodopsin by its C-terminal sequence QVS(A)PA
42. Transgenic mice carrying the dominant rhodopsin mutation P347S: Evidence for defective vectorial transport of rhodopsin to the outer segments
43. A rhodopsin gene mutation responsible for autosomal dominant retinitis pigmentosa results in a protein that is defective in localization to the photoreceptor outer segment
44. Identification of an outer segment targeting signal in the COOH terminus of rhodopsin using transgenic Xenopus laevis
45. P23H rhodopsin transgenic rat: Correlation of retinal function with histopathology
46. Immunochemical visualization and quantitation of cyclic AMP in single cells
47. The development of the rod photoresponse from dark-adapted rats
48. Mechanisms of rhodopsin inactivation in vivo as revealed by a COOH-terminal truncation mutant
49. Increased levels of 3′,5′-cyclic adenosine monophosphate induced by cobaltous ion or 3-isobutylmethylxanthine in the incubated mouse retina: Evidence concerning location and response to ions and light
50. Activation of caspase-3 in the retina of transgenic rats with the rhodopsin mutation s334ter during photoreceptor degeneration
51. Differential sensitivity of protein synthesis in human retina to a phosphodiesterase inhibitor and cyclic nucleotides
52. The cAMP-specific phosphodiesterase PDE4A5 is cleaved downstream of its SH3 interaction domain by caspase-3: Consequences for altered intracellular distribution
53. Melatonin receptor-mediated inhibition of cyclic AMP accumulation in chick retinal cell cultures
54. Melatonin receptor RNA is expressed in photoreceptors and displays a diurnal rhythm in Xenopus retina
55. Molecular and pharmacological identity of the alpha 2D-adrenergic receptor subtype in bovine retina and its photoreceptors
56. Type I calmodulin-sensitive adenylyl cyclase is neural specific
57. The effect of calcium channel blocker diltiazem on photoreceptor degeneration in the rhodopsin Pro23His rat
58. Regulation of cAMP by light and dopamine receptors is disfunctional in photoreceptors of dystrophic retinal degeneration slow (rds) mice
59. Characterization of the signaling interactions that promote the survival and growth of developing retinal ganglion cells in culture
60. Depolarization and cAMP elevation rapidly recruit TrkB to the plasma membrane of CNS neurons
61. Retinal ganglion cells lose trophic responsiveness after axotomy
62. Cyclic GMP and visual cell degeneration in the inherited disorder of rd mice: A progress report